Iron Sleep Quality Meta-analysis: What the Evidence Says

Quick Answer

Iron Sleep Quality Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 systematic review, 1 preclinical study.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• Insomnia, daytime sleepiness, mood changes, decreased adherence to treatment and increased cardiovascular risk through increased sympathetic activity have been reported to be linked with RLS severe form. [Zhang Juntao (2026); evidence level 1]
• Nevertheless, there is a lack of consistent evidence and safety concerns that make them not popular first-line treatment options. [Zhang Juntao (2026); evidence level 1]
• In addition, central lesions such as pontine stroke or spinal demyelinating plaques, and peripheral small-fiber neuropathies, have all been associated with RLS symptoms. [Ghattas Kyrillos (2026); evidence level 4]
• Nocturnal leg cramps are usually painful, focal, and associated with muscle tightening rather than an urge to move. [Ghattas Kyrillos (2026); evidence level 4]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For iron sleep quality meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Zhang Juntao (2026). Efficacy and safety of pharmacological treatments for restless legs syndrome in hemodialysis patients: a systematic review and meta-analysis. DOI: 10.3389/fneur.2026.1790771. PMCID: PMC13230204. PMID: 42246040. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13230204/
• Ghattas Kyrillos (2026). Restless Legs Syndrome and Neurological Comorbidities: A Narrative Review. DOI: 10.3390/jcm15103725. PMCID: PMC13206992. PMID: 42194685. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13206992/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.